Lv1
10 积分 2025-09-17 加入
Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis
11天前
已完结
Advances in Multiple Sclerosis
11天前
已完结
Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells
21天前
已完结
Comment on: Fcγ-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T cell therapy
27天前
已完结
Anti CD19 targeting CAR T cell therapy in ANCA-associated vasculitis
27天前
已完结
Chimeric antigen receptor-based cellular therapy in autoimmune diseases: A systematic review and meta-analysis of clinical, serological and safety outcomes
27天前
已完结
Chimeric antigen receptor-based cellular therapy in autoimmune diseases: A systematic review and meta-analysis of clinical, serological and safety outcomes
27天前
已完结
Chimeric antigen receptor-based cellular therapy in autoimmune diseases: A systematic review and meta-analysis of clinical, serological and safety outcomes
27天前
已完结
Shared and unique molecular signatures acrossdifferent autoantibody groups in systemic sclerosis:a multiomics analysis
3个月前
已完结
Heterogeneous responses of IM19 anti-CD19 CAR T-cell therapy in refractory systemic lupus erythematosus: an open-label pilot study and a mini-review
5个月前
已完结
皖公网安备34019202002308
